EVOLUS, INC. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
EVOLUS, INC. (EOLS) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $890.00 thousand as of 2018-12-31, per its 10-Q filed 2019-11-04.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2019-11-04
- 2018-12-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $890.00K.
- 2018-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $58.00K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $115.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2018-12-31 | $890.00K 10-Q · filed 2019-11-04 |
| 2018-09-30 | $58.00K 10-Q · filed 2018-11-05 |
| 2018-06-30 | $115.00K 10-Q · filed 2018-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |